Cargando…

P1592: MATCHED CONTROL COMPARISON OF SURVIVAL OF HOSPITALIZED COVID-19 PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, DATA FROM A LARGE TERTIARY CENTER REGISTRY

Detalles Bibliográficos
Autores principales:	Lucijanic, M., Soric, E., Sedinic, M., Sabljic, A., Tomasinec, S., Pasaric, A., Ivic, M., Vasilj, T., Cicic, D., Jonjic, Z., Pirsic, M., Mitrovic, Z., Prka, Z., Pejsa, V., Kusec, R., Jaksic, O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430565/ http://dx.doi.org/10.1097/01.HS9.0000849224.44414.a6

Ejemplares similares

Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients
por: Pejša, Vlatko, et al.
Publicado: (2017)

PB2127: NO IMPACT OF STATIN USE ON RESPONSE AND SURVIVAL RATES IN NEWLY DIAGNOSED DLBCL PATIENTS TREATED WITH R-DA-EPOCH
por: Sabljic, A., et al.
Publicado: (2022)

Thrombocytosis in COVID-19 patients without myeloproliferative neoplasms is associated with better prognosis but higher rate of venous thromboembolism
por: Lucijanic, Marko, et al.
Publicado: (2021)

P1691: COMPARISON OF IMPROVE, MODIFIED IMPROVE, IMPROVEDD AND PADUA RISK SCORES FOR VENOUS THROMBOEMBOLISM PREDICTION IN HOSPITALIZED COVID-19 PATIENTS
por: Lucijanic, M., et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
por: Lucijanic, Marko, et al.
Publicado: (2021)

Diffuse skin hyperpigmentation in CD30+ lymphoproliferation
por: Prka, Zeljko, et al.
Publicado: (2012)

Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2021)

Higher estimated plasma volume status is associated with increased thrombotic risk and impaired survival in patients with primary myelofibrosis
por: Lucijanic, Marko, et al.
Publicado: (2023)

PB2220: ATRIAL FIBRILLATION IS FREQUENT IN PATIENTS WITH MYELOFIBROSIS AND MIGHT BE SUB-OPTIMALLY TREATED
por: Lucijanic, Marko, et al.
Publicado: (2023)

PB2194: HIGHER JAK2 ALLELE BURDEN IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE NEOPLASMS IS ASSOCIATED WITH HIGHER PREVALENCE OF CHRONIC KIDNEY DISEASE AND UNFAVORABLE DYNAMICS OF KIDNEY FUNCTION OVER TIME
por: Lucijanic, Marko, et al.
Publicado: (2023)

PB2018: MULTIPLE MYELOMA WITH CENTRAL NERVOUS SYSTEM RELAPSE IN THE ERA OF NOVEL DRUGS - A MULTICENTER RETROSPECTIVE STUDY FROM THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL MALIGNANCIES (KROHEM)
por: Mitrovic, Z., et al.
Publicado: (2022)

Real-life experience with remdesivir for treatment of hospitalized coronavirus disease 2019 patients: matched case-control study from a large tertiary hospital registry
por: Lucijanić, Marko, et al.
Publicado: (2022)

P1040: HIGHER ESTIMATED PLASMA VOLUME STATUS IS ASSOCIATED WITH INCREASED THROMBOTIC RISK AND IMPAIRED SURVIVAL IN PATIENTS WITH PRIMARY MYELOFIBROSIS
por: Lucijanic, M., et al.
Publicado: (2022)

P1039: PALPABLE SPLEEN SIZE IS PROGNOSTIC IN PRIMARY BUT NOT SECONDARY MYELOFIBROSIS
por: Lucijanic, M., et al.
Publicado: (2022)

PReS13-SPK-1592: Pediatric aspects of antiphospholipid syndrome
por: Avcin, T
Publicado: (2013)

1592 Impact of HAART on Incidence of Primary HIV-Associated Thrombocytopenia
por: O'bryan, Thomas, et al.
Publicado: (2014)

1592. Safety of Oral Trimethoprim/Sulfamethoxazole Prophylaxis in Renal Transplant Recipients
por: Horvat, Courtney, et al.
Publicado: (2018)

Ruxolitinib withdrawal due to the COVID-19
por: Lucijanic, Marko, et al.
Publicado: (2021)

Risks associated with prior oral anticoagulation use in hospitalized COVID-19 patients – A retrospective cohort study on 5392 patients from a tertiary centre
por: Bistrovic, Petra, et al.
Publicado: (2023)

Red cell distribution width is a potent prognostic parameter for in-hospital and post-discharge mortality in hospitalized coronavirus disease 2019 patients: a registry-based cohort study on 3941 patients
por: Lucijanić, Marko, et al.
Publicado: (2022)

1592. In Vitro Activity of Ceftolozane/Tazobactam (C/T) Against Enterobacteriaceae and Pseudomonas aeruginosa Circulating in Chile
por: Rivas, Lina M, et al.
Publicado: (2019)

Understanding the physiology of the asymptomatic diaphragm of the M1592V hyperkalemic periodic paralysis mouse
por: Ammar, Tarek, et al.
Publicado: (2015)

P1110: EFFICACY AND SAFETY OF IMMUNOCHEMOTHERAPY IN TREATMENT OF FOLLICULAR NON-HODGKIN’S LYMPHOMA DURING COVID-19 PANDEMIC: A STUDY OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGIC DISEASES
por: Galusic, D., et al.
Publicado: (2022)

1592P Willingness to vaccinate and side effects of COVID-19 vaccination in patients with breast cancer and gynecological malignancies
por: Forster, M., et al.
Publicado: (2021)

Los Espacios Militares de San Luis Portosí, 1592-1847 : Una historia social y urbana de sus empalizadas, cuarteles y fortificaciones
por: Hernández Soubervielle, José Armando
Publicado: (2022)

Familial Normokalemic Periodic Paralysis Associated With Mutation in the SCN4A p.M1592V
por: Fu, Chao, et al.
Publicado: (2018)

P1692: PREDICTIVE MODEL FOR VEIN THROMBOEMBOLIC EVENTS DEVELOPMENT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
por: Mitrovic, M., et al.
Publicado: (2022)

PB1832: ARTERIAL THROMBOSIS AND ACUTE MYELOID LEUKEMIA – IS THERE A CONNECTION?
por: Pantic, N., et al.
Publicado: (2022)

Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
por: Galusic, Davor, et al.
Publicado: (2022)

P1592: EFFECTS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT) ON NEONATAL BIRTHWEIGHT: AN ANALYSIS USING SIBLING PAIRS
por: Mckelvy, Margaret, et al.
Publicado: (2023)

Galileo a Padova 1592-1610: celebrazioni del IV centenario - 7 dicembre 1991 - 7 dicembre 1992
por: Università di Padova. Padova
Publicado: (1995)

Galileo a Padova 1592 - 1610 : celebrazioni del IV centenario - 7 dicembre 1991 - 7 dicembre 1992
por: Santaniello, Giovanni
Publicado: (1995)

Galileo a Padova 1592 - 1610 : celebrazioni del IV centenario - 7 dicembre 1991 - 7 dicembre 1992
por: Università di Padova. Padova
Publicado: (1995)

Galileo a Padova 1592 - 1610 : celebrazioni del IV centenario - 7 dicembre 1991 - 7 dicembre 1992
por: Università di Padova. Padova
Publicado: (1995)

Galileo a Padova 1592-1610: celebrazioni del IV centenario - 7 dicembre 1991 - 7 dicembre 1992
por: Università di Padova. Padova
Publicado: (1995)

Physiological basis for muscle stiffness and weakness in a knock‐in M1592V mouse model of hyperkalemic periodic paralysis
por: Khogali, Shiemaa, et al.
Publicado: (2015)

Erratum: Influence of Composition and Plasma Power on Properties of Film from Biodegradable Polymer Blends. Polymers 2020, 12, 1592
por: Omaníková, Leona, et al.
Publicado: (2020)

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients
por: Montagna, M. T., et al.
Publicado: (2013)

The last battle of Alessandro Farnese (1545-1592): Some medical considerations regarding the health of the renaissance leader who changed Europe
por: Armocida, Emanuele, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08h8fbgib5lskr0o2o54t7psfl